Bellus Total Assets Trend from 2010 to 2022

BLU
 Stock
  

USD 11.63  1.26  12.15%   

Bellus Health Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets are likely to outpace its year average in 2022. From the period from 2010 to 2022, Bellus Health Total Assets quarterly data regression had r-squared of 0.60 and coefficient of variation of  123.00. Bellus Health Gross Profit is comparatively stable at the moment as compared to the past year. Bellus Health reported Gross Profit of 16,000 in 2021. Interest Expense is likely to gain to about 56.4 K in 2022, whereas Net Income is likely to drop (73.1 M) in 2022.
  
Check Bellus Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bellus main balance sheet or income statement drivers, such as Gross Profit of 16.4 K, Interest Expense of 56.4 K or Operating Expenses of 79.1 M, as well as many exotic indicators such as Asset Turnover of 9.0E-4, Book Value per Share of 3.83 or Current Ratio of 16.73. Bellus financial statements analysis is a perfect complement when working with Bellus Health Valuation or Volatility modules. It can also supplement Bellus Health's financial leverage analysis and stock options assessment as well as various Bellus Health Technical models . Continue to the analysis of Bellus Health Correlation against competitors.

Bellus Health Quarterly Total Assets

296.33 Million

Bellus Total Assets Breakdown

Showing smoothed Total Assets of Bellus Health with missing and latest data points interpolated. Total assets refers to the total amount of Bellus Health assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bellus Health books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; [Intangibles]; Property Plant and Equipment Net; Tax Assets and Trade and Non Trade Receivables.Bellus Health's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bellus Health's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 39.33 M10 Years Trend
Increasing
Slightly volatile
   Total Assets   
Share
       Timeline  

Bellus Total Assets Regression Statistics

Arithmetic Mean 89,253,747
Geometric Mean 52,997,594
Coefficient Of Variation 123.00
Mean Deviation 82,477,188
Median 28,498,000
Standard Deviation 109,785,133
Range 305,538,711
R-Value 0.77
R-Squared 0.60
Significance 0.001976
Slope 21,770,326

Bellus Total Assets History

201839.2 M
201996.4 M
2020153.1 M
2021309.6 M
2022334 M

About Bellus Health Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bellus Health income statement, its balance sheet, and the statement of cash flows. Bellus Health investors use historical funamental indicators, such as Bellus Health's Total Assets, to determine how well the company is positioned to perform in the future. Although Bellus Health investors may use each financial statement separately, they are all related. The changes in Bellus Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bellus Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bellus Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bellus Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Total Assets309.6 M334 M
Average Assets172.2 M149.6 M
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.

Bellus Health Investors Sentiment

The influence of Bellus Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bellus. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Bellus Health's public news can be used to forecast risks associated with investment in Bellus. The trend in average sentiment can be used to explain how an investor holding Bellus can time the market purely based on public headlines and social activities around Bellus Health. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Bellus Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bellus Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bellus Health's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Bellus Health.

Bellus Health Implied Volatility

    
  109.57  
Bellus Health's implied volatility exposes the market's sentiment of Bellus Health stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bellus Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bellus Health stock will not fluctuate a lot when Bellus Health's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bellus Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bellus Health's short interest history, or implied volatility extrapolated from Bellus Health options trading.

Pair Trading with Bellus Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bellus Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellus Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bellus Health

0.68MBRXMoleculin Biotech Earnings Call  This WeekPairCorr
0.79FOLDAmicus Therapeutics Upward RallyPairCorr

Moving against Bellus Health

0.68DMACDiamedica Therapeutics Earnings Call  This WeekPairCorr
0.63INMInmed Pharmaceuticals Fiscal Year End 23rd of September 2022 PairCorr
The ability to find closely correlated positions to Bellus Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bellus Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bellus Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bellus Health to buy it.
The correlation of Bellus Health is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bellus Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bellus Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bellus Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to the analysis of Bellus Health Correlation against competitors. Note that the Bellus Health information on this page should be used as a complementary analysis to other Bellus Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Bellus Stock analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.4 B
Return On Assets
-0.21
Return On Equity
-0.34
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.